Growth Metrics

Skinvisible (SKVI) Operating Expenses (2016 - 2026)

Skinvisible's Operating Expenses history spans 16 years, with the latest figure at $119169.0 for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 41.51% to $119169.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $516315.0, a 15.3% decrease, with the full-year FY2025 number at $516315.0, down 15.3% from a year prior.
  • Operating Expenses hit $119169.0 in Q4 2025 for Skinvisible, up from $111057.0 in the prior quarter.
  • Over the last five years, Operating Expenses for SKVI hit a ceiling of $203743.0 in Q4 2024 and a floor of $105315.0 in Q4 2021.
  • Historically, Operating Expenses has averaged $131062.2 across 5 years, with a median of $127881.5 in 2021.
  • Biggest five-year swings in Operating Expenses: soared 43.95% in 2024 and later crashed 41.51% in 2025.
  • Tracing SKVI's Operating Expenses over 5 years: stood at $105315.0 in 2021, then increased by 16.52% to $122716.0 in 2022, then increased by 15.34% to $141538.0 in 2023, then soared by 43.95% to $203743.0 in 2024, then plummeted by 41.51% to $119169.0 in 2025.
  • Business Quant data shows Operating Expenses for SKVI at $119169.0 in Q4 2025, $111057.0 in Q3 2025, and $141237.0 in Q2 2025.